All Things Considered for September 2, 2022 Hear the All Things Considered program for September 2, 2022

All Things Considered

The Corbevax vaccine was invented at the Center for Vaccine Development at Texas Children's Hospital and intended for countries that couldn't get access to more expensive COVID vaccines. India has inoculated millions of teens with Corbevax (above, a vaccination drive for children ages 12-14 at a school in Bangalore) and on August 10 authorized the vaccine as a booster for adults. Manjunath Kiran/AFP via Getty Images hide caption

toggle caption
Manjunath Kiran/AFP via Getty Images

Whatever happened to the new no-patent COVID vaccine touted as a global game changer?

  • Download
  • <iframe src="https://www.npr.org/player/embed/1119947342/1120798785" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Player advocates say the new exclusive broadcast deal signed by the Big Ten athletic conference is further evidence that college football is no longer amateurism. Dylan Buell/Getty Images hide caption

toggle caption
Dylan Buell/Getty Images

College football is back and players still aren't getting paid

  • Download
  • <iframe src="https://www.npr.org/player/embed/1120610858/1120798791" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Nicole Ogburn shows the new tool that she will use this year to know the emotional state of her students. Verónica G. Cárdenas for NPR hide caption

toggle caption
Verónica G. Cárdenas for NPR

This teacher survived the Uvalde shooting. Here's why she is returning to the job

  • Download
  • <iframe src="https://www.npr.org/player/embed/1120194145/1120798797" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Searching for a song you heard between stories? We've retired music buttons on these pages. Learn more here.

All Things Considered